At a glance
ClinicalIndex Comparison RecordN/ACompleted· 89 enrolled
Drug / intervention
Sapphire +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the CooperVision, Inc. Sapphire and Pearl Silicone Hydrogel Daily Wear Contact Lenses When Used for Frequent Replacement for Up to One (1) Month of Daily Wear.
In Brief
A clinical study evaluating Sapphire and Pearl for Ametropia. Completed, enrolled 89 participants across 6 sites.
Detailed Summary
The purpose of the study is to compare the investigational contact lens to a marketed contact lens. The study results were not used for design validation of investigational contact lens,
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
First PostedFeb 2015
Primary CompletionJun 2015
Study CompletionDec 2015
TodayJul 2026
First PostedFeb 13, 2015
Enrollment StartFeb 1, 2015
Primary CompletionJun 1, 2015
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 11.4 years ago
Interventions
Sapphiredevice
silicone hydrogel contact lens
Pearldevice
silicone hydrogel contact lens